Business Wire

Dr. Reddy's Laboratories Announces the Launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g Pump Actuation) in the U.S. Market

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
FierceBiotech

Endo Pharmaceuticals Receives FDA Approval for FORTESTA(TM) (Testosterone) Gel as a Class III Product for Topical Use for Men wi

Endo Pharmaceuticals Receives FDA Approval for FORTESTA(TM) (Testosterone) Gel as a Class III Product for Topical Use for Men with Low Testosterone FORTESTA Gel is the first approved testosterone ...
Monthly Prescribing Reference

Vogelxo Gel Approved for Testosterone Replacement

Upsher-Smith Laboratories announced it has received final approval from the FDA for its New Drug Application (NDA) for Vogelxo (testosterone) gel for topical use. Vogelxo is a Schedule CIII androgen ...
Nature

Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial

In the authors’ opinion and clinical experience, daily gel application can be disruptive to a patient’s routine. In theory, a higher concentration product should be more convenient because of lower ...